Cerebral embolic protection during transcatheter aortic valve replacement (tavr)
clinical event meta-analysis
Journal name: World Journal of Pharmaceutical Research
Original article title: Cerebral embolic protection during transcatheter aortic valve replacement (tavr)
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Subtitle: clinical event meta-analysis
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Ziad Eidhah Sharaf Alzahrani, Abdullah Ali Saeed Alzahrani, Abdulaziz Ibrahim Abbas Alghamdi, Abdulmohsin Ahmed Ali Alghamdi, Abdulraheem Ahmad Abdulraheem Alghamdi, Abdulrahman Mohammed Hassan Alzahrani, Majed Abdullah Mohammed Almuafa, Alabbas Saleh Abbas Alghamdi, Razan Mahmoud A. Alshaheen, Abdulhamid Mahmoud A. Alshaheen
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Cerebral embolic protection during transcatheter aortic valve replacement (tavr)
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr201913-16367
Download the PDF file of the original publication
Summary of article contents:
1) Introduction
Transcatheter aortic valve replacement (TAVR) is an emerging procedure for patients with severe symptomatic aortic valve stenosis who are deemed inoperable or at high risk for surgical intervention. Despite its advantages, TAVR is associated with an increased risk of neurological complications, particularly strokes, which can significantly affect both short- and long-term patient outcomes. The implementation of cerebral protection devices (CPDs) aims to mitigate this risk by preventing the embolization of debris during the procedure. This study provides a meta-analysis of the efficacy of cerebral embolic protection (EP) during TAVR.
2) The Role of Cerebral Embolic Protection
Cerebral protection devices function through either a filtering or deflection system. The filtering system acts like a net, capturing emboli from the bloodstream, while the deflection system reroutes emboli away from the cerebral circulation. This approach focuses on minimizing cerebral ischemic events that may arise as a consequence of the TAVR procedure. A systematic review of various studies examined the outcomes in patients utilizing EP compared to a control group, specifically looking at the rates of morbidity due to strokes and other neurologically significant events.
3) Efficacy in Clinical Outcomes
The meta-analysis identified six studies encompassing 1,185 patients, with a notable portion undergoing procedures with the use of EP. The results indicated a statistically significant reduction in mortality and stroke events in the EP group, with an odds ratio of 0.46, underscoring the protective effect of the device. However, differences in new ischemic lesions between the EP and control groups were not statistically significant. These findings suggest that while EP reduces the likelihood of severe outcomes like death or stroke, it might not effectively lower the incidence of all ischemic lesions detected post-procedure.
4) Comparisons with Previous Research
The findings of this analysis align with some prior research indicating significant risk reductions in mortality and strokes among patients using embolic protection devices. In contrast, certain studies failed to show conclusive benefits in outcomes between groups with and without EP utilization, pointing to the complexity of evaluating clinical endpoint efficacy. The variability in results highlights the need for further extensive and well-powered studies to definitively establish the role of EP in improving patient outcomes during TAVR.
5) Conclusion
In conclusion, the use of cerebral embolic protection devices during transcatheter aortic valve replacement appears to correlate with reduced mortality rates and improved early neurological outcomes in cardiac patients. However, the impact on new ischemic lesions remains inconclusive, warranting further investigation to better understand the utility of these devices. Continued research is essential to refine best practices and optimize patient safety and clinical outcomes during TAVR procedures.
FAQ section (important questions/answers):
What is the purpose of the study on Cerebral Embolic Protection?
The study aims to provide cumulative data on the effects of Cerebral Embolic Protection (EP) during Transcatheter Aortic Valve Replacement (TAVR) on cardiac patients.
How many studies were included in the meta-analysis?
A total of 6 studies involving 1185 patients were identified, with 656 patients in the EP group and 529 in the Control group.
What were the primary outcomes of the study?
The primary outcome was the occurrence of death or stroke events, which showed a significant decrease in the EP group compared to the Control group.
What results were found regarding new ischemic lesions?
The study found no significant difference in the rate of new ischemic lesions between the EP group and the Control group, indicating ineffective prevention.
What conclusion did the researchers draw from the study?
The researchers concluded that the use of EP is associated with reduced mortality rates and early clinical neurological effectiveness in TAVR patients.
What types of studies were considered for this meta-analysis?
The meta-analysis included randomized controlled trials (RCTs), clinical trials, and comparative studies specifically focused on TAVR patients with EP or Control group.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Cerebral embolic protection during transcatheter aortic valve replacement (tavr)”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Study (Studying):
The term 'Study' refers to the systematic investigation aimed at understanding the effects of Cerebral Embolic Protection during Transcatheter Aortic Valve Replacement (TAVR). It encompasses collected data, methodology, and analysis of outcomes related to cerebral protection in patients undergoing the procedure, contributing to evidence-based medical practices in cardiology.
2) Death:
In the context of this research, 'Death' denotes a critical outcome that the study aims to assess in relation to the use of embolic protection devices during TAVR. The impact on mortality is paramount in evaluating the safety and efficacy of medical interventions and helps to inform patient care strategies.
3) Relative:
'Relative' often refers to comparisons made between groups, such as the risk reduction or increase of certain events (like stroke or death) when using embolic protection devices compared to a control group. It provides context for understanding the magnitude of treatment effects in clinical research.
4) Table:
The term 'Table' indicates organized data representation that summarizes the characteristics of studies and important outcome measures. It allows readers to easily comprehend and compare information across different studies, helping to visualize and interpret the results and findings of the meta-analysis more effectively.
5) Male:
'Male' refers to a demographic aspect of the study participants, providing insight into the gender composition of the groups involved. Gender statistics can influence the interpretation of results, as biological sex may impact health outcomes and responses to treatments in cardiovascular research.
6) Forest:
'Forest' pertains to 'forest plots,' graphical representations used in meta-analysis to illustrate the results of individual studies and their overall effect. These plots display odds ratios and confidence intervals, visually conveying the strength of evidence from various studies regarding the efficacy of interventions examined.
7) Ovid:
Ovid is an online database where medical literature and journals are accessed. In this context, it indicates one of the platforms used for systematic literature search, emphasizing the importance of comprehensive investigation by gathering relevant studies that contribute to the meta-analysis of cerebral embolic protection.
8) Discussion:
'Discussion' refers to the section of the research where findings are interpreted and contextualized within a broader scientific framework. It involves comparing results with previous studies, addressing implications, and exploring limitations, ultimately guiding future research and clinical applications of the study results.
9) Doubt:
The term 'Doubt' may arise in the context of data interpretation or study inclusiveness. In medical research, ambiguity about study findings or methodologies can affect the credibility of results and provoke further investigation, signifying the necessity for clarity and robust study design to eliminate uncertainties.
10) Post:
'Post' indicates a timeframe or context following an event, such as 'post-TAVR,' which refers to the period after the Transcatheter Aortic Valve Replacement procedure. This term is crucial for analyzing outcomes related to patient recovery, complications, and effectiveness of interventions, helping to establish long-term strategies in care.